Home Tags Drugs
Drugs Related Content
Researchers say that the use of drugs to create glowing bacteria could decrease the need for prescribing antibiotics.
Manager EU Research at Centexbel, Guy Buyle introduces REMADYL, a H2020 project focused on the removal of legacy substances from PVC via a continuous and sustainable extrusion process.
Dr Christian Löfke, responsible for research and product development at BioBloom, walks us through the rudiments of essential oils as a potential modulator of the endocannabinoid system.
Joseph Najjar and Andrew K. Udit, PhD from the Department of Chemistry at Occidental College enlighten us on the importance of Cytochromes P450 in medicine and industry.
Prof Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH, shares a vision for remote decentralised clinical trials.
Here, Ilesol Pharmaceuticals discuss how they became the first European cannabinoid company to unlock this sector of the market.
Here, CBDepot discuss how they worked with the European Commission to achieve a “valid” Novel Food Application.
A new public health app by DRUID® measures factors to give an overall score of impairment, evolving the classic idea of drug testing.
Jay Sibbitts, Shu Jia, Obdulia Covarrubias-Zambrano, Stefan H. Bossmann and Christopher T Culbertson from Kansas State University’s Department of Chemistry walk us through what we need to know about microfluidic devices for detecting pain.
Health Canada led the world in large-scale cannabis legalisation and is now creating regulation for edible cannabis products: What is next?
Here, we discuss how unregulated industry patient advocates are integral to strengthening the credibility of growing CBD brands.
Michael A. Rogers outlines four necessary elements to increase further societal understanding about the use of cannabis edibles.
CEO of OC Care ApS, Christian Ohlendorff Hollensen, illuminates us on what we need to know about the cultivation of sustainable and organic medical cannabis in controlled environments, including the essential factor of lighting.
In the fourth of a series of five articles, Oxford Cannabinoid Technologies discuss their expertise on cannabinoids in medicine.
At Mile High Labs, we share a collective vision for global standards of CBD quality and compliance: Let’s discuss the Novel Food application process for the UK.
An international research team has made a breakthrough in stroke treatment, with a drug that could stop brain swelling without invasive surgery.
Prof Colin J Suckling OBE DSc FRSE from the Department of Pure & Applied Chemistry, details the ‘why’ and ‘what’ of academic drug discovery research at the University of Strathclyde, as well as his thoughts on the value of a chemistry degree.
Eos Scientific has commissioned research across a sample of more than 2000 UK adults exploring the growing shift in health-conscious millennials seeking CBD oil over prescriptions for mental health.
Dr. Jo Gee writes about working with personality disorders through her psychotherapy experience of over 10 years: Read on for what she has to say about mental health treatment.
Here, we find out how Minister for Health, Simon Harris TD is helping to support mental health services, as well as alcohol and drug use issues in Ireland.